[The development and clinical testing of antiarrhythmia drugs of a new chemical class].
Petrov
V I
VI
Spasov
A A
AA
Anisimova
V A
VA
Kirillov
O V
OV
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000638:Amiodarone / Q000627:therapeutic use; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000175:diagnosis / Q000188:drug therapy*; D001562:Benzimidazoles / Q000627:therapeutic use*; D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004562:Electrocardiography; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011342:Procainamide / Q000627:therapeutic use*; D014700:Verapamil / Q000627:therapeutic use*
C110746:9-diethylaminoethyl-2-tert-butylimidazo(1,2-a)benzimidazol; D000889:Anti-Arrhythmia Agents; D001562:Benzimidazoles; D002121:Calcium Channel Blockers; D014700:Verapamil; D011342:Procainamide; D000638:Amiodarone